Einhorn v. Culea

591 N.W.2d 908, 224 Wis. 2d 856, 1999 Wisc. App. LEXIS 214
CourtCourt of Appeals of Wisconsin
DecidedFebruary 24, 1999
Docket97-3592
StatusPublished
Cited by6 cases

This text of 591 N.W.2d 908 (Einhorn v. Culea) is published on Counsel Stack Legal Research, covering Court of Appeals of Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Einhorn v. Culea, 591 N.W.2d 908, 224 Wis. 2d 856, 1999 Wisc. App. LEXIS 214 (Wis. Ct. App. 1999).

Opinion

NETTESHEIM, J.

Section 180.0744, STATS., provides that if an independent special litigation committee (SLC) of a corporation has determined that a derivative action against the corporation is not in the corporation's best interest, the circuit court shall dismiss the action upon motion of the corporation.

Pursuant to this statute and following a trial on the issue of whether the members of the SLC were "independent," the circuit court dismissed Stephen Einhorn's amended complaint stating a derivative action against Northern Labs, Inc. and Northern Labs Manufacturing, Inc. (collectively Northern Labs) and James D. Culea, a majority stockholder and a member of the board of directors. Prior to this ruling, the court *859 had rejected Einhorn's direct action against Culea and directed that Einhorn instead file the derivative action.

Einhorn appeals. He raises the following challenges to the trial court's ruling: (1) the trial court erred when it refused to allow him to pursue a direct action against Culea; (2) the SLC was improperly created by Culea's lawyer in violation of § 180.0744, STATS.; (3) the members of the SLC were not independent and were inherently biased; and (4) the corporation's attorney compromised the SLC's independence by acting as the committee's counsel. We reject Einhorn's claims. Accordingly, we affirm.

BACKGROUND

Northern Labs, Inc. and Northern Labs Manufacturing, Inc. are located in Manitowoc, Wisconsin. Prior to 1986, Northern Labs was a subsidiary of S.C. Johnson Wax. Culea worked at Northern Labs as a division manager for S.C. Johnson Wax. In 1985, Culea, Ein-horn and Einhorn's business partner, Orville Mertz, formed an investor group which acquired Northern Labs in December 1985 for $3,648,000.

After the acquisition, the Northern Labs stock was distributed as follows: Culea 56.09%, Einhorn 20.60% and Mertz 20.06%. 1 The remainder of the stock was owned by other managers and directors. Culea has served as president, manager, director and majority shareholder of Northern Labs since 1986. Einhorn is a director and minority shareholder.

At the time of its acquisition, Northern Labs had annual sales of $16 million and generated little profit. *860 During the period between 1986 and 1992, Northern Labs' sales and profits increased. At the end of the 1993 fiscal year, Northern Labs was generating $33 million in sales and $1.9 million in profits.

In 1992, Culea sought a retroactive performance bonus because he had been undercompensated in the years following the acquisition. 2 In May 1992, he sent a notice to the directors of the company scheduling a compensation committee meeting and a board of directors meeting for July 29, 1992. At the time, the company's board of directors consisted of Culea, his wife, Shelly Culea, Einhorn, Mertz and the company's vice president of finance, Robert Bonk. Mertz, Culea and Bonk comprised the compensation committee.

On July 29, 1992, the compensation committee unanimously approved a retroactive bonus to Culea of $300,400, a portion of which would be paid with 1500 shares of Class B Northern Labs treasury stock which Culea valued at $122.23 per share. 3 A board of directors meeting was held immediately after. Einhorn did not attend the July 1992 meeting. The four board members in attendance — Culea, Mertz, Bonk and Shelly Culea — voted unanimously to adopt and ratify the compensation committee's decisions. Prior to the bonus award at the board meeting, Northern Labs' stock allocation had changed because Mertz and two other *861 stockholders had sold their shares for $122.23 per share. Following Culea's stock compensation, the allocations were: Einhorn 22%, Culea 76% and Bonk 2%. 4

On December 9,1993, Einhorn filed a direct action against Culea. Einhorn alleged that Culea had "willfully breached his fiduciary duties to Einhorn by participating in and causing the companies to implement a self-dealing retroactive bonus award of $300,000 to Culea and the self-dealing issuance to Culea of stock for no consideration or at best a grossly inadequate price." Einhorn alleged that as a result of Culea's "improper effort ... to squeeze [him] out," he had been "damaged by the dilution of his percentage ownership in the companies and by a reduction in the value of his interest in the companies . . . ." Einhorn sought a judgment ordering Culea to surrender the stock to Northern Labs and to reimburse Northern Labs for all cash payments received by him for retroactive bonus payments.

Culea responded in part that Einhorn's complaint failed to state a cause of action because the exclusive remedy for the alleged misconduct is set forth in the derivative action statutes. On May 3, 1994, Culea filed a motion for summary judgment arguing that: (1) the Northern Labs' bylaws and the Wisconsin and Delaware statutes permitted the board of directors to offer a bonus to Culea and issue stock to him, (2) the board of *862 directors' ratification of the compensation committee's recommendations is binding on the corporation and its shareholders, and (3) Einhorn improperly filed his suit in an individual capacity instead of in a derivative capacity. <

After considering arguments from both parties, the trial court issued a decision and order granting Culea's motion and giving Einhorn thirty days to amend his complaint to state a derivative action. Ein-horn did so, raising allegations similar to those in his original complaint.

Following Einhorn's amended complaint stating a derivative action, Northern Labs' board of directors was notified that, pursuant to § 180.0744, Stats., it would be voting on whether the maintenance of a derivative action was in the best interests of the corporation. At that time, the board of directors consisted of seven members. Pursuant to Northern Labs' articles of incorporation, five were appointed by Culea and two by Einhorn. Culea appointed himself, Shelly Culea, Robert Bonk and his neighbors, Dwight Chewning and Lolita Chua. Einhorn appointed himself and his business partner, John Beagle. 5

The board of directors met on December 16, 1994. Northern Labs' corporate counsel, Dennis W. Hollman, advised that because Einhorn, Culea and Shelly Culea had an interest in the dispute, they should not participate in any vote as directors or as potential members of any SLC which might be created. At this meeting, an SLC was created and Chewning, Bonk, Chua and Beagle were appointed as its members. After five months of meetings and approximately 500 hours of inquiry, a *863 majority of the SLC voted that the continuation of Ein-horn's derivative action was not in the best interests of the corporation.

Based on the SLC's vote and pursuant to § 180.0744(1), Stats., Culea filed a motion to dismiss Einhorn's derivative action.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burgess Ex Rel. BancorpSouth, Inc. v. Patterson
188 So. 3d 537 (Mississippi Supreme Court, 2016)
Sojitz America Capital Corp. v. Kaufman
61 A.3d 566 (Connecticut Appellate Court, 2013)
Notz v. Everett Smith Group, Ltd.
2008 WI App 84 (Court of Appeals of Wisconsin, 2008)
Einhorn v. Culea
2000 WI 65 (Wisconsin Supreme Court, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
591 N.W.2d 908, 224 Wis. 2d 856, 1999 Wisc. App. LEXIS 214, Counsel Stack Legal Research, https://law.counselstack.com/opinion/einhorn-v-culea-wisctapp-1999.